Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease

Dyskinetic disorders are characterized by excess of motor activity that may interfere with normal movement control. In patients with Parkinson’s disease, the chronic levodopa treatment induces dyskinetic movements known as levodopa-induced dyskinesias (LID). This paper analyzed the pathophysiology,...

Full description

Saved in:
Bibliographic Details
Main Authors: J. Guridi, R. González-Redondo, J. A. Obeso
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.1155/2012/943159
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564193735213056
author J. Guridi
R. González-Redondo
J. A. Obeso
author_facet J. Guridi
R. González-Redondo
J. A. Obeso
author_sort J. Guridi
collection DOAJ
description Dyskinetic disorders are characterized by excess of motor activity that may interfere with normal movement control. In patients with Parkinson’s disease, the chronic levodopa treatment induces dyskinetic movements known as levodopa-induced dyskinesias (LID). This paper analyzed the pathophysiology, clinical manifestations, pharmacological treatments, and surgical procedures to treat hyperkinetic disorders. Surgery is currently the only treatment available for Parkinson’s disease that may improve both parkinsonian motor syndrome and LID. However, this paper shows the different mechanisms involved are not well understood.
format Article
id doaj-art-59384cbfb9a646a5b27a2db2f2a933de
institution Kabale University
issn 2090-8083
2042-0080
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Parkinson's Disease
spelling doaj-art-59384cbfb9a646a5b27a2db2f2a933de2025-02-03T01:11:31ZengWileyParkinson's Disease2090-80832042-00802012-01-01201210.1155/2012/943159943159Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s DiseaseJ. Guridi0R. González-Redondo1J. A. Obeso2Department of Neurosurgery and Neurology, Clinica Universidad de Navarra, 31008 Pamplona, SpainDepartment of Neurosurgery and Neurology, Clinica Universidad de Navarra, 31008 Pamplona, SpainDepartment of Neurosurgery and Neurology, Clinica Universidad de Navarra, 31008 Pamplona, SpainDyskinetic disorders are characterized by excess of motor activity that may interfere with normal movement control. In patients with Parkinson’s disease, the chronic levodopa treatment induces dyskinetic movements known as levodopa-induced dyskinesias (LID). This paper analyzed the pathophysiology, clinical manifestations, pharmacological treatments, and surgical procedures to treat hyperkinetic disorders. Surgery is currently the only treatment available for Parkinson’s disease that may improve both parkinsonian motor syndrome and LID. However, this paper shows the different mechanisms involved are not well understood.http://dx.doi.org/10.1155/2012/943159
spellingShingle J. Guridi
R. González-Redondo
J. A. Obeso
Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Parkinson's Disease
title Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease
title_full Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease
title_fullStr Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease
title_full_unstemmed Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease
title_short Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease
title_sort clinical features pathophysiology and treatment of levodopa induced dyskinesias in parkinson s disease
url http://dx.doi.org/10.1155/2012/943159
work_keys_str_mv AT jguridi clinicalfeaturespathophysiologyandtreatmentoflevodopainduceddyskinesiasinparkinsonsdisease
AT rgonzalezredondo clinicalfeaturespathophysiologyandtreatmentoflevodopainduceddyskinesiasinparkinsonsdisease
AT jaobeso clinicalfeaturespathophysiologyandtreatmentoflevodopainduceddyskinesiasinparkinsonsdisease